Your guide to successful entry strategies in Germany, Spain, the UK, Italy and France
Webcode 25122202
Dr. Thomas Ecker
Ecker + Ecker GmbH, Hamburg
CEO;
Thomas Ecker is CEO of Ecker + Ecker. Since 2004 he has focused on HTA, Pricing and Reimbursement of pharmaceuticals. In that role he has been responsible for more than 100 G-BA submissions and price negotiations. His current focus is on EU HTA strategy and dossier development.
More information please click here.
Graham Foxon Ph.D. MBA
Remap Consulting GmbH, Cheshire, GREAT BRITAIN
Managing Director Graham co-founded Remap Consulting in 2014 with the mission to help clients optimise their pricing, health economics and market access outcomes. With over 20 years pharmceutical experience Graham brings unparalleled expertise in developing global product launch strategies and producing HTA submissions to adress payers' pricing and reimbursement requirements.
Andreas Schalueck
Simon-Kucher & Partners Strategy & Marketing Consultants GmbH, München
Manager - Life Sciences
Marta Taboada Rodríguez
World Health Management, Madrid, Spain
Partner, Head of Market Access Department Pharmaceutical Industry 25 years of experience in health facilities and Hospital administration. 6 years of experience in Market Access and Institutional Relations (RIMA).
Teresa Otero
World Health Management, Madrid, Spain
Expert in pharmaceutical law and drug evaluation and senior consultant
Bernd Schollmeier
Alira Health
Partner Global Market Access
09-10/12/2025
09-10/12/2025
09 December 2025: 9:00 am - 3:00 pm
10 December 2025: 9:00 am - 3:00 pm
online
online
Veranstaltung - 1,690 € zzgl. MwSt.
The participation fee includes downloadable documentation, a certificate, access to the Learning Space and technical support including PreMeeting.
Veranstaltung - 1,690 € zzgl. MwSt.
The participation fee includes downloadable documentation, a certificate, access to the Learning Space and technical support including PreMeeting.
Leila Grupp
Team Leader Pharma & Healthcare
+49 6221 500-695
l.grupp@forum-institut.de
This online seminar provides a comprehensive introduction to drug market access and pricing strategies in five key European countries: Germany, Spain, the UK, Italy, and France. Designed for beginners and professionals seeking structured insights into HTA systems, stakeholder roles, and pricing negotiations.
This intensive two-day seminar offers a detailed overview of current drug market access and pricing strategies across five key European countries: Germany, Spain, the United Kingdom, Italy, and France. Experts will outline each country’s unique regulatory landscape, value assessment methods, and negotiation processes with health authorities. Special emphasis will be placed on challenges related to innovative therapies.
By the end of the seminar, participants will be equipped with practical knowledge to navigate the complex and evolving reimbursement landscape in Europe.
By attending the seminar...
09:00 Introduction
09:15
Andreas Schalueck
10:15 break
10:30
Dr. Thomas Ecker
12:15 Lunch break
13:00
Marta Taboada Rodríguez, Teresa Otero
15:00 End of day 1
09:00
Graham Foxon Ph.D. MBA
09:00 Start of day 2
10:45 break
11:00
Bernd Schollmeier
12:30 Lunch break
13:15
Bernd Schollmeier
15:00 End of seminar
of 5 stars of all ratings from 2024
of 5 stars on Trustpilot = good
This course offers a deep dive into patient involvement in HTA processes across Europe, with a focus on the UK and Germa...
You will gain actionable insights into global pricing, market access strategies, payer evidence requirements, and health...
Using AI for clinical data evaluation, systematic literature reviews, dossier writing, and PICO simulations - the essent...
This seminar will focus on AMNOG and JCA dossier preparation as well as the German AMNOG procedure in comparison with th...
Join our one-day seminar on pharmaceutical law to gain a comprehensive overview of the key legal and regulatory principl...
